[Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications]
- PMID: 19292017
[Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications]
Abstract
Myocardial cell damage caused by myocardial ischemia results from several factors that include the duration of ischemia, oxygen demand by cardiomyocytes at the time of ischemia, and the presence and entity of collateral blood flow to the ischemic area. Importantly, myocardial cell injury may derive not only from ischemia itself but also from detrimental phenomena occurring during the restoration of myocardial blood flow after the ischemic episode (reperfusion damage). In the last decades a lot of studies have demonstrated that cardiomyocytes have several mechanisms that provide them protection against the damage deriving from ischemia-reperfusion, also allowing a prolongation of survival in the most severe cases. In this article we review some of these mechanisms, also discussing their present and/or potential therapeutic applications in the clinical setting. The topics include the interventions aimed at reducing cardiac work through a reduction of oxygen demand by myocardial cells or at optimizing the utilization of energetic resources by myocardial cells in situations of ischemia, the importance of phenomena such as ischemic preconditioning (early and delayed) and postconditioning of myocardial cells, and, finally, the theoretic possibility of interventions aimed at preventing cell death consequent to apoptosis.
Similar articles
-
[Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].Arch Cardiol Mex. 2006 Oct-Dec;76 Suppl 4:S76-101. Arch Cardiol Mex. 2006. PMID: 17469337 Review. Spanish.
-
[Trimetazidine and cardioprotection during ischemia-reperfusion].Ital Heart J. 2004 Mar;5 Suppl 2:29S-36S. Ital Heart J. 2004. PMID: 15074775 Review. Italian.
-
Metabolic disarrangement in ischemic heart disease and its therapeutic control.Rev Port Cardiol. 1998 Sep;17(9):667-84. Rev Port Cardiol. 1998. PMID: 9834638 Review.
-
Myocardial ischemia and reperfusion injury.Cardiovasc Pathol. 2005 Jul-Aug;14(4):170-5. doi: 10.1016/j.carpath.2005.03.006. Cardiovasc Pathol. 2005. PMID: 16009313 Review.
-
Ischaemic heart disease: clinical improvement with metabolic approach.Rev Port Cardiol. 2000 Nov;19 Suppl 5:V7-20. Rev Port Cardiol. 2000. PMID: 11206104 Review.
Cited by
-
Modulation of Angiotensin-II and Angiotensin 1-7 Levels Influences Cardiac Function in Myocardial Ischemia-reperfusion Injury.Curr Drug Res Rev. 2025;17(1):102-112. doi: 10.2174/0125899775280160240122065607. Curr Drug Res Rev. 2025. PMID: 38299413 Review.
-
Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3β signaling pathway.Exp Mol Med. 2011 Jan 31;43(1):53-61. doi: 10.3858/emm.2011.43.1.006. Exp Mol Med. 2011. PMID: 21270507 Free PMC article.